Adminstrative Core
行政核心
基本信息
- 批准号:7662917
- 负责人:
- 金额:$ 11.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-26 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:Arterial Fatty StreakAtherosclerosisBone MarrowCell SeparationCellsClinicCore FacilityDataDevelopmentEndothelial CellsEnsureEventFinancial SupportFutureGoalsGrantHistologyImage AnalysisImmunohistochemistryIndividualInflammatoryInstructionLesionManuscriptsModelingMusPopulationPreparationProcessProtocols documentationQuality ControlReagentResearchResearch PersonnelResourcesServicesSignal TransductionTechniquesTestingTrainingVascular Diseasesexperienceimprovedmacrophagememberprogramsresearch studytissue processingvascular inflammation
项目摘要
The Histology, Cell and Atheroma Core will provide five main services for investigators within the program
project. 1) Tissue Processing and Immuno- and Histological Analysis, 2) Photo-documentation, image
analysis and quantification and statistical testing of endpoint data for significance, 3) Mouse Lipidomic
Analysis, 4) Primary endothelial cell isolation training and quality control for purity and 5) Isolation and
culturing of bone marrow-derived macrophage training and reagents. The core has abundant experience and
will coordinate with co-director, Dr. Jonathan Smith, Cleveland Clinic, on the detailed and quantitative
analysis of atheroma lesions and murine lipidomics needed for these studies. Advanced histological
processing and immunohistochemistry will be available to all projects. A key issue in the program goals has
been the utilization of primary cell populations, primarily endothelial and bone marrow derived macrophage.
Since different labs and individuals are currently isolating primary cells with variable levels of efficiency and
application of quality control assessment of population purity, we have incorporated primary cell isolation and
analysis into the core. The support from the core will allow investigators to develop projects and experiments
without having technical difficulties with quantitative or cell isolation and analysis protocols is an integral
component of the program project, provides expanded opportunities and goals for each project and will
continue to be an indispensible resource for future efforts.
RELEVANCE (See instructions):
The Core Facility is necessary to support development of the individual projects. The application of specific
techniques and models in a uniform manner will improve the interpretation of results, cross interpretation
between projects and provide the most relevant information regarding the mechanisms of atherosclerosis
and inflammatory events in vascular disease.
组织学,细胞和动脉粥样硬化核心将提供五个主要服务的研究人员在该计划
项目1)组织处理、免疫学和组织学分析,2)照片记录,图像
终点数据的显著性分析、定量和统计学检验,3)小鼠脂质组学
分析,4)原代内皮细胞分离训练和纯度的质量控制,和5)分离和纯化,
骨髓源性巨噬细胞的培养训练和试剂。核心拥有丰富的经验,
我将与克利夫兰诊所的联合主任乔纳森·史密斯博士协调,
分析这些研究所需的动脉粥样硬化病变和鼠脂质组学。高级组织学
将为所有项目提供处理和免疫组织化学服务。方案目标中的一个关键问题是,
利用原代细胞群,主要是内皮和骨髓来源的巨噬细胞。
由于不同的实验室和个人目前正在以不同的效率水平分离原代细胞,
应用群体纯度的质量控制评估,我们将原代细胞分离和
分析核心。来自核心的支持将使研究人员能够开发项目和实验
没有定量或细胞分离和分析方案的技术困难
计划项目的组成部分,为每个项目提供了扩展的机会和目标,并将
继续是今后努力不可或缺的资源。
相关性(参见说明):
核心基金是支持个别项目发展所必需的。实施具体
技术和模型以统一的方式将改善结果的解释,交叉解释
并提供关于动脉粥样硬化机制的最相关信息
以及血管疾病中的炎症事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA H SHAPIRO其他文献
LINDA H SHAPIRO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA H SHAPIRO', 18)}}的其他基金
Role of CD13 and its activators in vascular inflammation
CD13及其激活剂在血管炎症中的作用
- 批准号:
8150053 - 财政年份:2010
- 资助金额:
$ 11.46万 - 项目类别:
The Role of CD13 and its activators in vascular inflammation
CD13及其激活剂在血管炎症中的作用
- 批准号:
7662916 - 财政年份:2009
- 资助金额:
$ 11.46万 - 项目类别:
CD13 as a Biomaker for Chemoprevention of Breast ca,
CD13 作为乳腺癌化学预防的生物制造者,
- 批准号:
7069507 - 财政年份:2005
- 资助金额:
$ 11.46万 - 项目类别:
CD13 as a Biomaker for Chemoprevention of Breast Cancer
CD13 作为乳腺癌化学预防的生物制造者
- 批准号:
7620059 - 财政年份:2005
- 资助金额:
$ 11.46万 - 项目类别:
CD13 as a Biomarker for Chemoprevention of Breast Cancer
CD13 作为乳腺癌化学预防的生物标志物
- 批准号:
6875826 - 财政年份:2005
- 资助金额:
$ 11.46万 - 项目类别:
CD13 as a Biomarker for NSAIDS Chemoprevention of Breast Cancer
CD13 作为 NSAIDS 化学预防乳腺癌的生物标志物
- 批准号:
7416712 - 财政年份:2005
- 资助金额:
$ 11.46万 - 项目类别:
CD13 as a Biomarker for NSAIDS Chemoprevention of Breast Cancer
CD13 作为 NSAIDS 化学预防乳腺癌的生物标志物
- 批准号:
7249485 - 财政年份:2005
- 资助金额:
$ 11.46万 - 项目类别:
相似海外基金
Bone marrow-derived cell mobilization promotes the progression of atherosclerosis and tissue regeneration
骨髓来源的细胞动员促进动脉粥样硬化和组织再生的进展
- 批准号:
23790878 - 财政年份:2011
- 资助金额:
$ 11.46万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Elucidation of the determinants of atherosclerosis progression in transplanted hearts using bone marrow transplantation
利用骨髓移植阐明移植心脏动脉粥样硬化进展的决定因素
- 批准号:
12670641 - 财政年份:2000
- 资助金额:
$ 11.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Progression of atherosclerosis: involvement of mural thrombi and bone marrow cells
动脉粥样硬化的进展:附壁血栓和骨髓细胞的参与
- 批准号:
nhmrc : 961223 - 财政年份:1996
- 资助金额:
$ 11.46万 - 项目类别:
NHMRC Project Grants














{{item.name}}会员




